FR2424026A1 - Medicaments a base d'ethers hydrosolubles d'hydroxyflavones pour le traitement des affections decoulant de la fragilite et de la permeabilite des capillaires sanguins - Google Patents

Medicaments a base d'ethers hydrosolubles d'hydroxyflavones pour le traitement des affections decoulant de la fragilite et de la permeabilite des capillaires sanguins

Info

Publication number
FR2424026A1
FR2424026A1 FR7911196A FR7911196A FR2424026A1 FR 2424026 A1 FR2424026 A1 FR 2424026A1 FR 7911196 A FR7911196 A FR 7911196A FR 7911196 A FR7911196 A FR 7911196A FR 2424026 A1 FR2424026 A1 FR 2424026A1
Authority
FR
France
Prior art keywords
ethers
hydrosolubble
hydroxyflavon
fragility
permeability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7911196A
Other languages
English (en)
Other versions
FR2424026B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA
Original Assignee
Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA filed Critical Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA
Publication of FR2424026A1 publication Critical patent/FR2424026A1/fr
Priority to JP1468780A priority Critical patent/JPS55143913A/ja
Application granted granted Critical
Publication of FR2424026B1 publication Critical patent/FR2424026B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/07—Benzo[b]pyran-4-ones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

CES MEDICAMENTS SONT CONSTITUES PAR LES ETHERS HYDROSOLUBLES D'HYDROXYFLAVONES, OBTENUS PAR REACTION D'HYDROXYFLAVONES AVEC DES HALOGENURES D'ALKYL SUBSTITUES, DE FORMULE GENERALE: (CF DESSIN DANS BOPI) DANS LAQUELLE R H OU CHCHOH OU 6-0-A-L-RAMNOSIL-D-GLUCOSYLE, R H OU CHCHOH ET R H OU CHCHOH. ILS S'APPLIQUENT CHEZ L'HOMME PAR VOIES ORALE, RECTALE, PARENTERALE OU TOPIQUE A DES DOSES COMPRISES ENTRE 50 ET 300MG, DE PRINCIPE ACTIF DANS LES FORMES GALENIQUES APPROPRIEES, SEULS OU ASSOCIES AVEC D'AUTRES SUBSTANCES D'ACTIVITE SYNERGIQUE OU COMPLEMENTAIRE, A RAISON DE 3 A 8 DOSES PAR JOUR.
FR7911196A 1978-04-25 1979-04-24 Medicaments a base d'ethers hydrosolubles d'hydroxyflavones pour le traitement des affections decoulant de la fragilite et de la permeabilite des capillaires sanguins Granted FR2424026A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1468780A JPS55143913A (en) 1979-04-24 1980-02-08 Drug for treating disease in capillay vessel fragility and permeability

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES469101A ES469101A1 (es) 1978-04-25 1978-04-25 Procedimiento de obtencion de eteres hidrosolubles de hidro-xiflavonas.

Publications (2)

Publication Number Publication Date
FR2424026A1 true FR2424026A1 (fr) 1979-11-23
FR2424026B1 FR2424026B1 (fr) 1983-05-06

Family

ID=8475915

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7824069A Granted FR2424267A1 (fr) 1978-04-25 1978-08-10 Procede d'obtention d'ethers hydrosolubles d'hydroxyflavones
FR7911196A Granted FR2424026A1 (fr) 1978-04-25 1979-04-24 Medicaments a base d'ethers hydrosolubles d'hydroxyflavones pour le traitement des affections decoulant de la fragilite et de la permeabilite des capillaires sanguins

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR7824069A Granted FR2424267A1 (fr) 1978-04-25 1978-08-10 Procede d'obtention d'ethers hydrosolubles d'hydroxyflavones

Country Status (6)

Country Link
CH (1) CH636097A5 (fr)
DE (1) DE2832857A1 (fr)
ES (1) ES469101A1 (fr)
FR (2) FR2424267A1 (fr)
IT (1) IT1158899B (fr)
PT (1) PT68322B (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003865A1 (fr) * 1984-03-01 1985-09-12 Casley Smith John Royle Traitement des oedemes a forte teneur en proteines chez les animaux
WO1985003864A1 (fr) * 1984-03-01 1985-09-12 Casley Smith John Royle Traitement des oedemes a forte teneur en proteines par application directe de benzo-pyrones
EP0198965A1 (fr) * 1984-01-10 1986-10-29 Lamorna Investments Proprietary Limited Benzopyrones pour le traitement de maculopathie exudative ou disciforme

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8707969A1 (es) * 1986-05-09 1987-10-01 Espanola Prod Quimicos Procedimiento de preparacion de una mezcla estandar de o-(b-hidroxietil)-diosminas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH342963A (de) * 1955-12-30 1959-12-15 Joos Bernhard Verfahren zur Darstellung wasserlöslicher Derivate von Polyoxyflavonoiden
DE1061327B (de) * 1957-07-04 1959-07-16 Zyma S A Nyon Verfahren zur Herstellung eines Rutin-tri-(oxyaethyl)-aethers
CH581127A5 (fr) * 1974-04-09 1976-10-29 Zyma Sa

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0198965A1 (fr) * 1984-01-10 1986-10-29 Lamorna Investments Proprietary Limited Benzopyrones pour le traitement de maculopathie exudative ou disciforme
WO1985003865A1 (fr) * 1984-03-01 1985-09-12 Casley Smith John Royle Traitement des oedemes a forte teneur en proteines chez les animaux
WO1985003864A1 (fr) * 1984-03-01 1985-09-12 Casley Smith John Royle Traitement des oedemes a forte teneur en proteines par application directe de benzo-pyrones
US5096887A (en) * 1984-03-01 1992-03-17 Lamorna Investments Proprietary Limited Treatment of high protein oedemas

Also Published As

Publication number Publication date
CH636097A5 (en) 1983-05-13
IT1158899B (it) 1987-02-25
DE2832857A1 (de) 1979-11-08
PT68322B (fr) 1994-02-22
PT68322A (fr) 1978-07-31
IT7826417A0 (it) 1978-08-02
FR2424267B1 (fr) 1983-02-04
FR2424026B1 (fr) 1983-05-06
ES469101A1 (es) 1978-11-16
FR2424267A1 (fr) 1979-11-23

Similar Documents

Publication Publication Date Title
YU113690A (sh) Postupak za dobivanje askorbinske kiseline
PT64770B (fr) Procede pour la preparation d'une composition insecticide contenant ethers benzoilureide-difenilicos.
BE828050A (fr) Procede de carboxymethylation d'alcools ou d'etheralcools
PT64771B (fr) Procede pour la preparation d'une composition insecticide contenant ethers benzoilureide-nitro-difenilicos.
FR2424026A1 (fr) Medicaments a base d'ethers hydrosolubles d'hydroxyflavones pour le traitement des affections decoulant de la fragilite et de la permeabilite des capillaires sanguins
NL191108B (nl) Farmaceutische waterige cis-platin oplossing.
BE825653A (fr) Compositions pharmaceutiques antibiotiques contenant le sel de sodium de l'acide 7- (d-2-formyloxy-2- phenylace tamido -3- 1-methyl-14-tetrazole-5-yl-thiomethyl)-3-cephem-40-carboxylique
FR2387230A1 (fr) Nouvelles pyrroloquinoxalines et leurs sels, procede de preparation et application a titre de medicaments
PT80791A (fr) Procede de preparation de nouvelles phenyl-naphtiridines utiles notamment comme medicaments anti-ulceres
KR830006286A (ko) 빈카민 사카리내이트의 제조방법
PT74744A (fr) Procede de preparation de derives de phenethanolamine et de compositions pharmaceutiques les contenant
ES8530002A1 (es) Un procedimiento para la preparacion de agentes antibacterianos unidos de dicarboxilato de 1,1-alcanodiol
FR2442840A1 (fr) Procede de preparation de cetones diglycidyliques insaturees photopolymerisables
FR2428628A1 (fr) Sel sodique de mercaptopropionylglycine, procede pour sa preparation et utilisations therapeutiques
FI832007A0 (fi) En ny mikroorganismstam chromobacterium violaceum, medelst denna stam framstaellda farmaceutiskt aktiva foereningar, ett foerfarande foer framstaellning av foereningarna och anvaendning av dessa foereningar som laekemedel
EA199800218A1 (ru) Фармацевтический препарат с трипанозидными свойствами
KR840004361A (ko) 암의 치료용 "하이폭시데시-"(Hypoxidaceae)과의 식물 추출물
BE822342A (fr) Procede de preparation de dispersions aqueuses d'interpolymeresa faible viscosite
OA06150A (fr) Polysaccharides de xanthomonas utilisables pour préparer des gels aqueux de filtrabilité améliorée.
SE8206128L (sv) Farmaceutisk komposition for behandling av njurstenar framkallade genom infektion
BE832830A (fr) Procede de preparation d'hydroxy-3 triazoles-1,2,4,
FR2288729A1 (fr) Procede de preparation d'acide 5-(2, 4-difluorophenyl) salicylique
RO63717A (fr) Procede d'obtention de la riphamicine s par la hydrolyse de la riphamicine o
BE883695A (fr) Procede de preparation d'alcool 3,3-dimethyl-allylique
NO820180L (no) Basisk substituert antranilsyrer, fremgangsmaate til deres fremstilling og deres anvendelse

Legal Events

Date Code Title Description
ST Notification of lapse